You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selumetinib, Differentiated Thyroid Cancer , AZD6244

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Differentiated Thyroid Cancer Patients Treated With Different

Not yet recruiting
  • Thyroid Cancer
  • (no location specified)
Nov 15, 2023

Differentiated Thyroid Cancer Trial in Worldwide (Selumetinib, Placebo, Radioactive Iodine Therapy)

Terminated
Has Results
  • Differentiated Thyroid Cancer
  • Birmingham, Alabama
  • +44 more
Aug 27, 2019

MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

Not yet recruiting
  • MPNST
  • +2 more
  • Birmingham, Alabama
  • +13 more
Jun 29, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

Completed
  • Lung Cancer
  • +7 more
  • Chicago, Illinois
  • +5 more
Nov 15, 2019

18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

Recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +2 more
  • Computed Tomography
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

Recruiting
  • Thyroid Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 17, 2023

Quality of Life in Differentiated Thyroid Carcinoma Undergoing

Not yet recruiting
  • Thyroid Cancer
  • minimally invasive procedure
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hopsital
Sep 13, 2023

Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

Not yet recruiting
  • Thyroid Cancer
  • 20 mg Famitinib & 1200 mg Adebrelimab
  • (no location specified)
Nov 26, 2023

Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

Recruiting
  • Differentiated Thyroid Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 9, 2023

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

Pathological Manifestation in Thyroid Follicular Neoplasm: Early

Not yet recruiting
  • Thyroid Cancer
  • Follicular Thyroid Cancer
    • (no location specified)
    Jul 20, 2022

    Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)

    Recruiting
    • Thyroid Cancer
    • Traditional neck dissection approach
    • Anterior neck dissection approach
    • Medellin, Antioquia, Colombia
      Hospital Alma Mater de Antioquia
    Nov 20, 2023

    Renal Tracer Elimination in Thyroid Cancer Patients Treated With

    Completed
    • Thyroid Carcinoma
      • Jena, Thüringen, Germany
        University Hospital Jena
      Dec 15, 2022

      Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

      Not yet recruiting
      • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
      • Anlotinib Hydrochloride Capsule and Penpulimab
      • Beijing, Beijing, China
        YansongLin
      Sep 25, 2023

      Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • Pavia, Lombardia, Italy
        Istituti Clinici Scientifici Maugeri
      May 5, 2023

      Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • +3 more
      • Larotrectinib monotherapy
      • 131I therapy
      • (no location specified)
      Mar 13, 2023

      Efficacy of Lenvatinib in Differentiated Thyroid Cancer

      Recruiting
      • Differentiated Thyroid Cancer
      • Gender
      • Rome, Italy
        Regina Elena National Cancer Institute
      Mar 16, 2023

      Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

      Recruiting
      • Neurofibromatosis Type 1
      • +2 more
      • London, United Kingdom
      • +1 more
      Nov 11, 2021

      Galectin-3 in Papillary Thyroid Carcinoma

      Not yet recruiting
      • Galactin 3-thyroid Carcinoma
        • (no location specified)
        Jan 26, 2023

        Recurrence in Patients With Differentiated Thyroid Cancer

        Not yet recruiting
        • Differentiated Thyroid Cancer
        • (no location specified)
        Nov 30, 2023

        Thyroid Tumors Trial in India (Lenvatinib)

        Active, not recruiting
        • Thyroid Neoplasms
        • New Delhi, Delhi, India
        • +10 more
        Jul 15, 2022

        Reminder System (TCARS) Study - A Pilot Study.

        Not yet recruiting
        • Low Risk Differentiated Thyroid Cancer
        • Shared-care model
        • (no location specified)
        Aug 18, 2022

        Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

        Active, not recruiting
        • Muscle Invasive Bladder Cancer
        • Los Angeles, California
        • +26 more
        Oct 17, 2022

        Differentiated Thyroid Cancer Trial in China (AL2846 capsule)

        Recruiting
        • Differentiated Thyroid Cancer
        • AL2846 capsule
        • Guilin, Guangxi, China
        • +3 more
        Feb 27, 2023